• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用心脏磁共振指纹技术对心脏淀粉样变性进行特征描述。

Characterization of cardiac amyloidosis using cardiac magnetic resonance fingerprinting.

机构信息

Imaging Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Department of Radiology, Department of Biomedical Engineering, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA.

出版信息

Int J Cardiol. 2022 Mar 15;351:107-110. doi: 10.1016/j.ijcard.2021.12.038. Epub 2021 Dec 25.

DOI:10.1016/j.ijcard.2021.12.038
PMID:34963645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8857016/
Abstract

BACKGROUND

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy with poor prognosis absent appropriate treatment. Elevated native myocardial T and T have been reported for CA, and tissue characterization by cardiac MRI may expedite diagnosis and treatment. Cardiac Magnetic Resonance Fingerprinting (cMRF) has the potential to enable tissue characterization for CA through rapid, simultaneous T and T mapping. Furthermore, cMRF signal timecourses may provide additional information beyond myocardial T and T.

METHODS

Nine CA patients and five controls were scanned at 3 T using a prospectively gated cMRF acquisition. Two cMRF-based analysis approaches were examined: (1) relaxometric-based linear discriminant analysis (LDA) using native T and T, and (2) signal timecourse-based LDA. The Fisher coefficient was used to compare the separability of patient and control groups from both approaches. Leave-two-out cross-validation was employed to evaluate the classification error rates of both approaches.

RESULTS

Elevated myocardial T and T was observed in patients vs controls (T: 1395 ± 121 vs 1240 ± 36.4 ms, p < 0.05; T: 36.8 ± 3.3 vs 31.8 ± 2.6 ms, p < 0.05). LDA scores were elevated in patients for relaxometric-based LDA (0.56 ± 0.28 vs 0.18 ± 0.13, p < 0.05) and timecourse-based LDA (0.97 ± 0.02 vs 0.02 ± 0.02, p < 0.05). The Fisher coefficient was greater for timecourse-based LDA (60.8) vs relaxometric-based LDA (1.6). Classification error rates were lower for timecourse-based LDA vs relaxometric-based LDA (12.6 ± 24.3 vs 22.5 ± 30.1%, p < 0.05).

CONCLUSIONS

These findings suggest that cMRF may be a valuable technique for the detection and characterization of CA. Analysis of cMRF signal timecourse data may improve tissue characterization as compared to analysis of native T and T alone.

摘要

背景

心脏淀粉样变性(CA)是一种预后不良的浸润性心肌病,缺乏适当的治疗方法。已有研究报道 CA 患者的心肌固有 T1 和 T2 值升高,心脏 MRI 的组织特征分析可能有助于加速诊断和治疗。心脏磁共振指纹技术(cMRF)有可能通过快速、同时的 T1 和 T2 映射来实现 CA 的组织特征分析。此外,cMRF 信号时间曲线可能提供比心肌 T1 和 T2 更多的信息。

方法

在 3T 上使用前瞻性门控 cMRF 采集对 9 例 CA 患者和 5 例对照者进行扫描。检查了两种基于 cMRF 的分析方法:(1)基于弛豫的线性判别分析(LDA),使用固有 T1 和 T2;(2)基于信号时间曲线的 LDA。采用 Fisher 系数比较两种方法对患者和对照组的可分离性。采用留二法交叉验证评估两种方法的分类错误率。

结果

与对照组相比,患者的心肌 T1 和 T2 值升高(T1:1395±121 比 1240±36.4 ms,p<0.05;T2:36.8±3.3 比 31.8±2.6 ms,p<0.05)。基于弛豫的 LDA(0.56±0.28 比 0.18±0.13,p<0.05)和基于信号时间曲线的 LDA(0.97±0.02 比 0.02±0.02,p<0.05)的 LDA 评分在患者中升高。基于信号时间曲线的 LDA 的 Fisher 系数大于基于弛豫的 LDA(60.8 比 1.6)。基于信号时间曲线的 LDA 的分类错误率低于基于弛豫的 LDA(12.6%±24.3 比 22.5%±30.1%,p<0.05)。

结论

这些发现表明,cMRF 可能是检测和特征分析 CA 的一种有价值的技术。与单独分析固有 T1 和 T2 相比,分析 cMRF 信号时间曲线数据可能会改善组织特征分析。

相似文献

1
Characterization of cardiac amyloidosis using cardiac magnetic resonance fingerprinting.应用心脏磁共振指纹技术对心脏淀粉样变性进行特征描述。
Int J Cardiol. 2022 Mar 15;351:107-110. doi: 10.1016/j.ijcard.2021.12.038. Epub 2021 Dec 25.
2
Free-running cardiac magnetic resonance fingerprinting: Joint T1/T2 map and Cine imaging.自由运行心脏磁共振指纹技术:T1/T2 联合图谱和电影成像。
Magn Reson Imaging. 2020 May;68:173-182. doi: 10.1016/j.mri.2020.02.005. Epub 2020 Feb 13.
3
Simultaneous Mapping of T and T Using Cardiac Magnetic Resonance Fingerprinting in a Cohort of Healthy Subjects at 1.5T.在1.5T场强下,利用心脏磁共振指纹成像技术对一组健康受试者同时进行T1和T2 mapping
J Magn Reson Imaging. 2020 Oct;52(4):1044-1052. doi: 10.1002/jmri.27155. Epub 2020 Mar 28.
4
Water-fat Dixon cardiac magnetic resonance fingerprinting.水脂分离 Dixon 心脏磁共振指纹成像
Magn Reson Med. 2020 Jun;83(6):2107-2123. doi: 10.1002/mrm.28070. Epub 2019 Nov 18.
5
Cardiac MR fingerprinting with a short acquisition window in consecutive patients referred for clinical CMR and healthy volunteers.连续临床 CMR 检查和健康志愿者的短采集窗心脏磁共振指纹技术。
Sci Rep. 2022 Nov 4;12(1):18705. doi: 10.1038/s41598-022-23573-3.
6
Cardiac cine magnetic resonance fingerprinting for combined ejection fraction, T and T quantification.心脏电影磁共振指纹技术用于联合射血分数、T 值和 T* 值定量测量。
NMR Biomed. 2020 Aug;33(8):e4323. doi: 10.1002/nbm.4323. Epub 2020 Jun 5.
7
3D free-breathing cardiac magnetic resonance fingerprinting.3D 自由呼吸心脏磁共振指纹成像技术。
NMR Biomed. 2020 Oct;33(10):e4370. doi: 10.1002/nbm.4370. Epub 2020 Jul 21.
8
Myocardial T and T quantification and water-fat separation using cardiac MR fingerprinting with rosette trajectories at 3T and 1.5T.采用 3T 和 1.5T 罗纹轨迹心脏磁共振指纹技术对心肌 T 和 T 定量及水脂分离。
Magn Reson Med. 2021 Jan;85(1):103-119. doi: 10.1002/mrm.28404. Epub 2020 Jul 27.
9
Deep learning reconstruction for cardiac magnetic resonance fingerprinting T and T mapping.深度学习在心脏磁共振指纹 T 和 T 映射中的重建。
Magn Reson Med. 2021 Apr;85(4):2127-2135. doi: 10.1002/mrm.28568. Epub 2020 Oct 26.
10
Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis.非延迟钆增强心脏磁共振参数在心脏淀粉样变性中的诊断和预后价值。
Curr Probl Cardiol. 2023 Apr;48(4):101573. doi: 10.1016/j.cpcardiol.2022.101573. Epub 2022 Dec 28.

引用本文的文献

1
Next-Generation Cardiac Magnetic Resonance Imaging Techniques for Characterization of Myocardial Disease.用于心肌疾病特征描述的下一代心脏磁共振成像技术
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):243-254. doi: 10.1007/s11936-024-01044-4. Epub 2024 Aug 9.
2
Evaluation of myocarditis with a free-breathing three-dimensional isotropic whole-heart joint T1 and T2 mapping sequence.使用自由呼吸三维各向同性全心联合T1和T2映射序列评估心肌炎。
J Cardiovasc Magn Reson. 2024;26(2):101100. doi: 10.1016/j.jocmr.2024.101100. Epub 2024 Sep 19.
3
Cardiac MR Fingerprinting: Overview, Technical Developments, and Applications.心脏磁共振指纹技术:概述、技术进展与应用。
J Magn Reson Imaging. 2024 Nov;60(5):1753-1773. doi: 10.1002/jmri.29206. Epub 2023 Dec 28.
4
MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal Liver Lesions.磁共振指纹技术在无对比剂条件下对肝脏局灶性病变的定量特征分析。
Radiol Imaging Cancer. 2023 Nov;5(6):e230036. doi: 10.1148/rycan.230036.
5
Motion-compensated T mapping in cardiovascular magnetic resonance imaging: a technical review.心血管磁共振成像中的运动补偿T映射:技术综述
Front Cardiovasc Med. 2023 Sep 8;10:1160183. doi: 10.3389/fcvm.2023.1160183. eCollection 2023.
6
Cardiac Magnetic Resonance Fingerprinting: Potential Clinical Applications.心脏磁共振指纹技术:潜在的临床应用。
Curr Cardiol Rep. 2023 Mar;25(3):119-131. doi: 10.1007/s11886-022-01836-9. Epub 2023 Feb 18.
7
Fingerprinting MINOCA: Unraveling Clues With Quantitative CMR.心肌梗死伴非阻塞性冠状动脉病变的指纹识别:通过定量心脏磁共振成像解开线索
JACC Case Rep. 2023 Feb 1;7:101722. doi: 10.1016/j.jaccas.2022.101722.
8
Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches.心脏代谢疾病中的定量磁共振成像:从传统的心脏和肝脏组织成像技术到多参数方法。
Front Cardiovasc Med. 2023 Jan 23;9:991383. doi: 10.3389/fcvm.2022.991383. eCollection 2022.
9
Simultaneous multi-parametric acquisition and reconstruction techniques in cardiac magnetic resonance imaging: Basic concepts and status of clinical development.心脏磁共振成像中的同步多参数采集与重建技术:基本概念与临床发展现状
Front Cardiovasc Med. 2022 Oct 6;9:953823. doi: 10.3389/fcvm.2022.953823. eCollection 2022.

本文引用的文献

1
Magnetic resonance fingerprinting residual signals can disassociate human grey matter regions.磁共振指纹残留信号可以分离人类灰质区域。
Brain Struct Funct. 2022 Jan;227(1):313-329. doi: 10.1007/s00429-021-02402-9. Epub 2021 Oct 25.
2
Cardiac magnetic resonance fingerprinting: Trends in technical development and potential clinical applications.心脏磁共振指纹技术:技术发展趋势及潜在临床应用。
Prog Nucl Magn Reson Spectrosc. 2021 Feb;122:11-22. doi: 10.1016/j.pnmrs.2020.10.001. Epub 2020 Nov 6.
3
Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.弥散张量心血管磁共振在心脏淀粉样变性中的应用。
Circ Cardiovasc Imaging. 2020 May;13(5):e009901. doi: 10.1161/CIRCIMAGING.119.009901. Epub 2020 May 15.
4
Simultaneous Mapping of T and T Using Cardiac Magnetic Resonance Fingerprinting in a Cohort of Healthy Subjects at 1.5T.在1.5T场强下,利用心脏磁共振指纹成像技术对一组健康受试者同时进行T1和T2 mapping
J Magn Reson Imaging. 2020 Oct;52(4):1044-1052. doi: 10.1002/jmri.27155. Epub 2020 Mar 28.
5
Contrast-free high-resolution 3D magnetization transfer imaging for simultaneous myocardial scar and cardiac vein visualization.对比剂-free 高分辨率 3D 磁化传递成像,用于同时显示心肌瘢痕和心静脉。
MAGMA. 2020 Oct;33(5):627-640. doi: 10.1007/s10334-020-00833-9. Epub 2020 Feb 20.
6
Magnetization transfer in magnetic resonance fingerprinting.磁共振指纹识别中的磁化传递
Magn Reson Med. 2020 Jul;84(1):128-141. doi: 10.1002/mrm.28096. Epub 2019 Nov 25.
7
Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.心肌固有 T2 测量可区分轻链和转甲状腺素蛋白心脏淀粉样变性并评估预后。
J Cardiovasc Magn Reson. 2018 Aug 16;20(1):58. doi: 10.1186/s12968-018-0478-3.
8
Diffusion-weighting Caused by Spoiler Gradients in the Fast Imaging with Steady-state Precession Sequence May Lead to Inaccurate T Measurements in MR Fingerprinting.快速稳态进动序列中的扰相梯度引起的扩散加权可能导致磁共振指纹成像中 T 测量不准确。
Magn Reson Med Sci. 2019 Jan 10;18(1):96-104. doi: 10.2463/mrms.tn.2018-0027. Epub 2018 May 24.
9
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.非对比 T1 映射在心脏淀粉样变性诊断中的应用。
JACC Cardiovasc Imaging. 2013 Apr;6(4):488-97. doi: 10.1016/j.jcmg.2012.11.013. Epub 2013 Mar 14.
10
Texture analysis of multiple sclerosis: a comparative study.多发性硬化症的纹理分析:一项比较研究。
Magn Reson Imaging. 2008 Oct;26(8):1160-6. doi: 10.1016/j.mri.2008.01.016. Epub 2008 May 29.